COVID 19 Vaccine Trials in China

COVID19 Vaccine: Phase-2 Clinical Trials in China

COVID-19 has created havoc all over the world. Everyone wants to know when this pandemic is going to end, is there a vaccine available that can help curb the spread.

Coronavirus Vaccine News China

Well, currently, no vaccines have proved to be productive work to protect people from this scary virus, but attempts by researchers are going on, and multiple candidates are under progress. About COVID-19 vaccine trials in China, there are five vaccine candidates. Preliminary clinic trial results were positive and expected to test in a Phase 3 trial in Brazil, said by China’s vaccine maker Sinovac Biotech.

As per the Institute of Medical Biology at the Chinese Academy of Medical Sciences (IMBCAMS), Chinese researchers have started the second trial of their potential corona virus vaccine. With several vaccines are in different stages of tests globally, none of the trials have passed large-scale. The phase-2 human test is one of the six vaccines that Chinese researchers are developing against the corona virus. The first phase held in May recruited around 200 individuals to participate in the test. Phase-2 COVID-19   vaccine trials in China will emphasize the immune responses while determining the shot’s dose. This year, China expected to use a plant to produce a corona virus vaccine to meet China’s future vaccine supplies. By the end of 2020, people with special needs may use experimental vaccines under urgent circumstances, by Gao Fu (Director at the Chinese Center for Disease Control and Prevention). As per China National Biotec Group and UAE state media, China and The United Arab Emirates have launched a Phase 3 Clinical trial of a COVID-19 Vaccine China.

On June 24, 2020, this trial agreement was signed between the two countries by the G42 and the Sinopharm Group, a leading research-based pharmaceutical company and affiliate of CNBG. This collaboration is not the only vaccine at the phase 3 stage, but also the University of Oxford has begun a phase 3 trials on its vaccine with 30, 000 participants in July.

Globally, the researchers are putting efforts to find a corona virus vaccine. However, it is still unsure whether a vaccine will be available to the public, but there is a hope to produce it by early 2021.

Vaccines undergo multiple phase trials to ensure effectiveness and safety. According to the US Centers for Disease Control and Prevention, clinical development takes three phases. Phase 1 includes small groups of people to get the trial vaccine. A larger group with people having similar characteristics is involved in the phase 2 trial. A phase 3 trial can be a critical moment which may use to confirm results from phase and phase 2 vaccine trials.

The report by the World Health Organization reveals that there are 16 candidate vaccines in clinical evaluation and a further 125 in preclinical evaluation.

And while scientists and researchers are in a battle to win the Coronavirus vaccine, there is still no guarantee of how and when one will find.